Abstract:Objectives Pyogenic arthritis, pyoderma gangrenosum and acne (PAPA) syndrome is characterised by flares of sterile arthritis with neutrophil infiltrate and the overproduction of interleukin (IL)-1β. The purpose of this study was to elucidate the potential role of neutrophil subsets and neutrophil extracellular traps (NET) in the pathogenesis of PAPA. Methods Neutrophils and low-density granulocytes (LDG) were quantified by flow cytometry. Circulating NETs were measured by ELISA and PAPA serum was tested for the ability to degrade NETs. The capacity of NETs from PAPA neutrophils to activate macrophages was assessed. Skin biopsies were analysed for NETs and neutrophil gene signatures. Results Circulating LDGs are elevated in PAPA subjects. PAPA neutrophils and LDGs display enhanced NET formation compared with control neutrophils. PAPA sera exhibit impaired NET degradation and this is corrected with exogenous DNase1. Recombinant human IL-1β induces NET formation in PAPA neutrophils but not healthy control neutrophils. NET formation in healthy control neutrophils is induced by PAPA serum and this effect is inhibited by the IL-1 receptor antagonist, anakinra. NETs from PAPA neutrophils and LDGs stimulate IL-6 release in healthy control macrophages. NETs are detected in skin biopsies of patients with PAPA syndrome in association with increased tissue IL-1β, IL-8 and IL-17. Furthermore, LDG gene signatures are detected in PAPA skin. Conclusions PAPA syndrome is characterised by an imbalance of NET formation and degradation that may enhance the half-life of these structures in vivo, promoting inflammation. Anakinra ameliorates NET formation in PAPA and this finding supports a role for IL-1 signalling in exacerbated neutrophil responses in this disease. The study also highlights other inflammatory pathways potentially pathogenic in PAPA, including IL-17 and IL-6, and these results may help guide new therapeutic approaches in this severe and often treatment-refractory condition.

Proteasome-associated autoinflammatory syndrome 2 in a neonate

Haploinsufficiency of PSMD12 Causes Proteasome Dysfunction and Subclinical Autoinflammation

Neonatal Presentation of Familial Glucocorticoid Deficiency with a MRAP Mutation: One Case Report

[Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-linked Syndrome in Two Cases].

Identification of eight novel proteasome variants in five unrelated cases of proteasome-associated autoinflammatory syndromes (PRAAS)

A Chinese case of Nakajo–Nishimura syndrome with novel compound heterozygous mutations of the PSMB8 gene

Case Report: Profound newborn leukopenia related to a novel RAC2 variant

Identification of of a PAX2 Mutation from Maternal Mosaicism Causes Recurrent Renal Disorder in Siblings

Case report: Primary immunodeficiency due to a novel mutation in CARMIL2 and its response to combined immunomodulatory therapy

Case report: Infantile generalized pustular psoriasis with IL36RN and CARD14 gene mutations

Prenatal Diagnosis of Apert Syndrome Due to A De Novo FGFR2 Mutation at the Second Trimester: a Case Report

Low-ratio somatic NLRC4 mutation causes late-onset autoinflammatory disease

Generalized pustular psoriasis in a toddler with IL36RN mutation: a case report

Dysregulated neutrophil responses and neutrophil extracellular trap formation and degradation in PAPA syndrome

Combined Immunodeficiency Caused by a Novel De Novo Gain-of-Function RAC2 Mutation

A Case Report of Pulmonary Alveolar Proteinosis Masquerading as Respiratory Distress Syndrome in Preterm Neonates

Novel mutation in the NRLP3 manifesting as an intermediate phenotype of cryopyrinopathies

First maternal uniparental disomy for chromosome 2 with PREPL novel frameshift mutation of congenital myasthenic syndrome 22 in an infant.

Case report on activated PI3K-delta syndrome

Monozygotic triplets with juvenile-onset autoimmunity and 18p microdeletion involving PTPRM

P02-023 - NLRP3 Mosaicism As a Cause of Late-Onset CAPS